Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

THE TREATMENT OF BRONCHIAL ASTHMA WITH VACCINES

THE TREATMENT OF BRONCHIAL ASTHMA WITH VACCINES Abstract In a recent article1 it was shown that 191, or 48 per cent., of patients with bronchial asthma were sensitive to some type of protein. In a more recent article2 the results of treatment with proteins of 100 of the sensitive patients was given; this 100 included only those patients who were sensitive to the proteins of animal hair and emanations and of food. The present paper concerns those patients who were treated with vaccines and represents a total of 178 individuals. Twenty-eight of these patients were sensitive to bacterial proteins, and therefore these patients were treated with vaccines of the organisms to which they were sensitive. The remaining 150 patients included in this paper were not sensitive to any protein with which they were tested. Since these nonsensitive patients are a part of the whole series of 400 cases, 48 per cent. of whom were found to be sensitive, References 1. Walker, I. C.: A Clinical Study of 400 Patients with Bronchial Asthma , Boston M. and S. J. 179:288, 1918.Crossref 2. Walker, I. C.: Treatment of Bronchial Asthma with Proteins , Archives Int. Med. 22:466, 1918.Crossref 3. Arch. Int. Med. 22:466, 1918. 4. Study III , Jour. Med. Research 35:487, 1917. 5. Study XIV , Jour. Med. Research 36:423, 1917. 6. This gram-negative staining bacillus, which will be frequently mentioned, was more or less motile, sometimes only sluggishly motile, at other times very actively motile; in the litmus-sugar-serum waters it reacted like the colon type of bacillus although it did not produce indol in Dunham's peptone solution. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

THE TREATMENT OF BRONCHIAL ASTHMA WITH VACCINES

Archives of Internal Medicine , Volume 23 (2) – Feb 1, 1919

Loading next page...
 
/lp/american-medical-association/the-treatment-of-bronchial-asthma-with-vaccines-qxjTnuxeeq

References (6)

Publisher
American Medical Association
Copyright
Copyright © 1919 American Medical Association. All Rights Reserved.
ISSN
0730-188X
DOI
10.1001/archinte.1919.00090190090008
Publisher site
See Article on Publisher Site

Abstract

Abstract In a recent article1 it was shown that 191, or 48 per cent., of patients with bronchial asthma were sensitive to some type of protein. In a more recent article2 the results of treatment with proteins of 100 of the sensitive patients was given; this 100 included only those patients who were sensitive to the proteins of animal hair and emanations and of food. The present paper concerns those patients who were treated with vaccines and represents a total of 178 individuals. Twenty-eight of these patients were sensitive to bacterial proteins, and therefore these patients were treated with vaccines of the organisms to which they were sensitive. The remaining 150 patients included in this paper were not sensitive to any protein with which they were tested. Since these nonsensitive patients are a part of the whole series of 400 cases, 48 per cent. of whom were found to be sensitive, References 1. Walker, I. C.: A Clinical Study of 400 Patients with Bronchial Asthma , Boston M. and S. J. 179:288, 1918.Crossref 2. Walker, I. C.: Treatment of Bronchial Asthma with Proteins , Archives Int. Med. 22:466, 1918.Crossref 3. Arch. Int. Med. 22:466, 1918. 4. Study III , Jour. Med. Research 35:487, 1917. 5. Study XIV , Jour. Med. Research 36:423, 1917. 6. This gram-negative staining bacillus, which will be frequently mentioned, was more or less motile, sometimes only sluggishly motile, at other times very actively motile; in the litmus-sugar-serum waters it reacted like the colon type of bacillus although it did not produce indol in Dunham's peptone solution.

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Feb 1, 1919

There are no references for this article.